Relationship between COVID-19 cases and monthly mortality from all causes, cancer, cardiovascular diseases and diabetes in 16 countries, 2020–21 DOI

Margherita Pizzato,

Claudia Santucci, Nazrul Islam

et al.

International Journal of Epidemiology, Journal Year: 2024, Volume and Issue: 54(1)

Published: Dec. 16, 2024

Abstract Background During the COVID-19 pandemic, mortality from some chronic diseases increased. In this study, we evaluated monthly excess all causes, cancer, cardiovascular (CVD) and diabetes during months of 2020 2021, examining its relationship with cases. Methods Monthly cause-specific data were downloaded public repositories national statistics offices or directly requested them, population obtained United Nations archives. Excess deaths estimated as difference between observed expected deaths. for 2021 calculated using a quasi-Poisson regression model trained on 2010–19 (or shorter timespan if full decade was not available). To quantify correlation cases mortality, used Spearman’s coefficient (rs). Results The study included 16 countries that provided causes death (Argentina, Austria, Brazil, Switzerland, Chile, Czech Republic, Germany, Georgia, Hungary, Italy, Lithuania, Latvia, Mexico, Serbia, Slovakia USA). A positive found in (rs ranging 0.61 to 0.91), CVD 11 0.45 0.85) 13 0.42 0.79). above 5% 14 both seven nine 12 2021. No cancer any considered. Conclusions persisted several throughout These increases coincide peaks, supporting short-term impact pandemic these causes.

Language: Английский

National trends in Azithromycin consumption during 2017–2023 in Kazakhstan: impact of the COVID-19 pandemic and the imperative for enhanced clinical guidelines DOI Creative Commons
Laura Kassym, Assiya Kussainova, Д. В. Семенов

et al.

Scientific Reports, Journal Year: 2025, Volume and Issue: 15(1)

Published: Feb. 21, 2025

Antibiotic resistance (AMR) has reached critical levels globally, especially in developing economies like Kazakhstan, largely due to improper antibiotic use. The aim of this study was examine seven years azithromycin sales data Kazakhstan uncover consumption patterns during the COVID-19 pandemic and develop effective strategies combat AMR. This analyzes two sets: one from a comprehensive review documents regulating use Kazakhstan. second set consists pharmaco-epidemiological analysis procurement provided by Vi-ORTIS. Azithromycin (ATC group J01FA10) 2017 2023 measured DDD/1000 inhabitants/day (DID) using ATC/DDD methodology. is extensively used adult pediatric care Its consumption, DDD per 1,000 inhabitants, surged 2020 with outbreak. steady annual increase "Watch" antibiotics, including azithromycin, should alarm Kazakhstan's healthcare system. trend highlights need for stronger stewardship programs, targeted interventions, monitoring prevent overuse misuse. Addressing crucial maintaining effectiveness safeguarding public health.

Language: Английский

Citations

0
Cause-specific excess mortality in Denmark, Finland, Norway, and Sweden during the COVID-19 pandemic 2020–2022: a study using nationwide population data DOI Creative Commons
Anton Nilsson, Louise Emilsson, Kasper P. Kepp

et al.

European Journal of Epidemiology, Journal Year: 2024, Volume and Issue: 39(9), P. 1037 - 1050

Published: Sept. 1, 2024

Abstract While there is substantial evidence on excess mortality in the first two years of COVID-19 pandemic, no study has conducted a cause-specific analysis for whole period 2020–2022 across multiple countries. We examined during Denmark, Finland, Norway, and Sweden—four countries with similar demographics welfare provisions, which implemented different pandemic response policies. To this end, we utilized nationwide register-based information annual deaths stratified by age sex, applied linear regression models to predict based reference 2010–2019. Excess were obtained contrasting actual expected deaths. Additional analyses employed standardization common population, as well population adjustments account previous Our results showed that, besides due (a total 32,491 2020–2022), all experienced cardiovascular diseases (in 11,610 deaths), under-mortality respiratory other than 9878) dementia 8721). The was particularly pronounced Finland Norway 2022, Sweden 2021–2022. In conclusion, while emerge most apparent consequence our findings suggest that also been influenced substitutions between causes death over time, indirect consequences infection responses—albeit extents

Language: Английский

Citations

2
Relationship between COVID-19 cases and monthly mortality from all causes, cancer, cardiovascular diseases and diabetes in 16 countries, 2020–21 DOI

Margherita Pizzato,

Claudia Santucci, Nazrul Islam

et al.

International Journal of Epidemiology, Journal Year: 2024, Volume and Issue: 54(1)

Published: Dec. 16, 2024

Abstract Background During the COVID-19 pandemic, mortality from some chronic diseases increased. In this study, we evaluated monthly excess all causes, cancer, cardiovascular (CVD) and diabetes during months of 2020 2021, examining its relationship with cases. Methods Monthly cause-specific data were downloaded public repositories national statistics offices or directly requested them, population obtained United Nations archives. Excess deaths estimated as difference between observed expected deaths. for 2021 calculated using a quasi-Poisson regression model trained on 2010–19 (or shorter timespan if full decade was not available). To quantify correlation cases mortality, used Spearman’s coefficient (rs). Results The study included 16 countries that provided causes death (Argentina, Austria, Brazil, Switzerland, Chile, Czech Republic, Germany, Georgia, Hungary, Italy, Lithuania, Latvia, Mexico, Serbia, Slovakia USA). A positive found in (rs ranging 0.61 to 0.91), CVD 11 0.45 0.85) 13 0.42 0.79). above 5% 14 both seven nine 12 2021. No cancer any considered. Conclusions persisted several throughout These increases coincide peaks, supporting short-term impact pandemic these causes.

Language: Английский

Citations

0